Actelion Acquires CoTherix For $420 mil.

Swiss firm projects that sales of its newly acquired product Ventavis could add roughly $100 mil. in 2007 revenue.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet